KSB301 (CB-2431): Began Phase IIb testing

KS Biomedix Holdings Plc (LSE:KSB), London, U.K.

Read the full 70 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE